drugset / Trial / NCT01483651
Physiologic Response to Glucagon at Varying Insulin Levels
Completed
11 enrolled
Legacy Health System
Juvenile Diabetes Research Foundation · collabOregon Health and Science University · collab
RandomizedCrossoverSingle-blindBasic science
Summary
The purpose of this research study is to test how different levels of insulin block the effect of glucagon. Insulin is a hormone that lowers blood glucose. Glucagon raises blood glucose. Both are natural hormones made by people without diabetes. Sensor-based blood glucose control studies have been done by our research group using glucagon in small doses to prevent hypoglycemia (low blood sugar). However, sometimes glucagon does not work to raise blood sugar. The investigators believe this is because of too much insulin in the body. This study will help determine how different levels of insulin in the body affect the ability of glucagon to raise blood sugar.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucagon | Peptide | 10 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 25 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 45 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 70 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 100 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 135 ug | Subcutaneous |
| Subject | Glucagon | Peptide | 175 ug | Subcutaneous |
| Subject | Insulin | Protein / enzyme biologic | 0.01 iu/kg | Intravenous |
| Subject | Insulin | Protein / enzyme biologic | 0.02 iu/kg | Intravenous |
| Subject | Insulin | Protein / enzyme biologic | 0.04 iu/kg | Intravenous |
| Subject | Insulin | Protein / enzyme biologic | 0.08 iu/kg | Intravenous |